Pendulum Therapeutics Introduces GLP-1 Probiotic
SAN FRANCISCO, March 13, 2024 /PRNewswire/ -- Pendulum Therapeutics, a female-led biotech company pioneering the next frontier of metabolic health through its microbiome-targeted products, announces the launch of their GLP-1 Probiotic. This revolutionary product empowers people to take control of their metabolic health by naturally increasing GLP-1, the "un-hunger" hormone that the body naturally produces when you eat. The Pendulum probiotic is formulated with beneficial bacterial strains known to stimulate GLP-1 production (based on preclinical studies), and reduce appetite and cravings. Participants in GLP-1 Probiotic consumer research reported significant reduction in food cravings after 6 weeks. 91% reported reduced overall food cravings and 88% reported reduced sugar cravings.
- GLP-1 Probiotic is a powerful, effective, and science-backed tool to help naturally boost GLP-1 production and naturally help maintain a healthy weight*
SAN FRANCISCO, March 13, 2024 /PRNewswire/ -- Pendulum Therapeutics , a female-led biotech company pioneering the next frontier of metabolic health through its microbiome-targeted products, announces the launch of their GLP-1 Probiotic. - The Pendulum probiotic is formulated with beneficial bacterial strains known to stimulate GLP-1 production (based on preclinical studies), and reduce appetite and cravings.
- Participants in GLP-1 Probiotic consumer research reported significant reduction in food cravings after 6 weeks.
- "We are proud to extend the Pendulum probiotic portfolio with the launch of GLP-1 Probiotic.